Further committing to its nation-building efforts, Lina Manufacturing – the pharmaceutical manufacturing segment of Sunshine Healthcare Lanka (SHL), recently signed a contract manufacturing agreement with TRUVIC Private Limited. The partnership will help Lina to fulfill its corporate purpose of bringing good things to the lives of Sri Lankans through quality, affordable pharma products.
Lina Manufacturing has been engaged in the pharmaceutical manufacturing sector for over ten years and is a thriving local manufacturer supplying a large variety of respiratory products to the Government sector and private sector. Lina has pioneered the development of local respiratory products with its patented Respiratory Inhaler Device and continues to invest significantly in R&D to introduce more products. As Sri Lanka’s first Respiratory Care Research and Manufacturing facility, Lina Manufacturing produces a range of respiratory pharmaceuticals and devices, including Beclovent, Flutivent, Salbuvent, Prazolin, Winterpan and the award-winning Ventohaler inhalers.
In December 2020, Sunshine Holdings announced its healthcare business’s strategic merger consisting of Sunshine Healthcare Lanka and Healthguard Pharmacy with Akbar Pharmaceuticals, Lina Manufacturing and Lina Spiro—the business units of Akbar Healthcare. The merger’s finalisation elevated Sunshine Healthcare as Sri Lanka’s first fully integrated healthcare company, starting from manufacturing up to retailing healthcare products, including last-mile distribution across the country for all healthcare products. The company now operates in all five segments of the healthcare supply chain, namely research and development (R&D), manufacturing, importation, distribution and retail.
TRUVIC Private Limited markets high-quality pharmaceutical and consumer healthcare products, which are offered at affordable prices to the general public in Sri Lanka and other Asian countries. Driven by the visionary leadership of its founder Palitha Thenuwara, TruVic has reached millions of people through its ever-growing supply and distribution network. The company is strengthened by its partnerships with pharmaceutical industry leaders in India, Bangladesh, Pakistan Australia and Sri Lanka and other principals
